Role of AFP mRNA expression in peripheral blood as a predictor for postsurgical recurrence of hepatocellular carcinoma: a systematic review and meta-analysis
- PMID: 15849829
- PMCID: PMC4305761
- DOI: 10.3748/wjg.v11.i17.2656
Role of AFP mRNA expression in peripheral blood as a predictor for postsurgical recurrence of hepatocellular carcinoma: a systematic review and meta-analysis
Abstract
Aim: To identify the role of alpha-fetoprotein (AFP) mRNA expression in peripheral blood one week after surgery as a predictor for recurrence of hepatocellular carcinoma (HCC).
Methods: Published studies fulfilling the selection criteria were identified by searching several databases online. After a methodology assessment using a quality scale designed by European Lung Cancer Working Party, data in each research were aggregated by means of meta-analysis.
Results: Altogether 368 cases were included in the 9 selected studies, which fulfilled the selection criteria. The quality scores ranged from 35% to 84% with a median score of 55%. The 'design' subscore had the lowest median value (38%). By aggregating the data, a high chi2 value (77.576) was presented. The fail-safe number was 136 and 64 for P = 0.05 and 0.01, respectively.
Conclusion: AFP mRNA expression in peripheral blood 1 wk after surgery correlated with the recurrence of HCC and was a good predictor for tumor recurrence.
Similar articles
-
Surveillance of cirrhosis for hepatocellular carcinoma: systematic review and economic analysis.Health Technol Assess. 2007 Sep;11(34):1-206. doi: 10.3310/hta11340. Health Technol Assess. 2007. PMID: 17767898
-
Platelet-to-lymphocyte ratio in the setting of liver transplantation for hepatocellular cancer: A systematic review and meta-analysis.World J Gastroenterol. 2018 Apr 21;24(15):1658-1665. doi: 10.3748/wjg.v24.i15.1658. World J Gastroenterol. 2018. PMID: 29686473 Free PMC article.
-
Test characteristics of alpha-fetoprotein for detecting hepatocellular carcinoma in patients with hepatitis C. A systematic review and critical analysis.Ann Intern Med. 2003 Jul 1;139(1):46-50. doi: 10.7326/0003-4819-139-1-200307010-00012. Ann Intern Med. 2003. PMID: 12834318
-
Nomogram for predicting early cancer-related death due to recurrence after liver resection in hepatocellular carcinoma patients with Barcelona Clinic Liver Cancer (BCLC) stage B/C: a multicenter study.BMC Gastroenterol. 2025 Jan 12;25(1):14. doi: 10.1186/s12876-025-03588-6. BMC Gastroenterol. 2025. PMID: 39800706 Free PMC article.
-
Alpha-fetoprotein and/or liver ultrasonography for liver cancer screening in patients with chronic hepatitis B.Cochrane Database Syst Rev. 2003;(2):CD002799. doi: 10.1002/14651858.CD002799. Cochrane Database Syst Rev. 2003. Update in: Cochrane Database Syst Rev. 2012 Sep 12;(9):CD002799. doi: 10.1002/14651858.CD002799.pub2. PMID: 12804438 Updated.
Cited by
-
Biomarkers for hepatocellular carcinoma.Int J Hepatol. 2012;2012:859076. doi: 10.1155/2012/859076. Epub 2012 May 10. Int J Hepatol. 2012. PMID: 22655201 Free PMC article.
-
Clinicopathological significance and prognostic value of the expression of the cancer stem cell marker CD133 in hepatocellular carcinoma: a meta-analysis.Tumour Biol. 2015 Sep;36(10):7623-30. doi: 10.1007/s13277-015-3487-y. Epub 2015 Apr 29. Tumour Biol. 2015. PMID: 25921286
-
Diagnosis of hepatocellular carcinoma.World J Gastroenterol. 2009 Mar 21;15(11):1301-14. doi: 10.3748/wjg.15.1301. World J Gastroenterol. 2009. PMID: 19294759 Free PMC article. Review.
-
Serum tumor markers for detection of hepatocellular carcinoma.World J Gastroenterol. 2006 Feb 28;12(8):1175-81. doi: 10.3748/wjg.v12.i8.1175. World J Gastroenterol. 2006. PMID: 16534867 Free PMC article. Review.
-
Effect of Bcl-2 and Bax on survival of side population cells from hepatocellular carcinoma cells.World J Gastroenterol. 2007 Dec 7;13(45):6053-9. doi: 10.3748/wjg.v13.45.6053. World J Gastroenterol. 2007. PMID: 18023099 Free PMC article.
References
-
- Parkin DM. Global cancer statistics in the year 2000. Lancet Oncol. 2001;2:533–543. - PubMed
-
- Yang LY, Huang GW. Surgical strategy of large hepatocellular carcinoma. Linchuang Waike Zazhi. 2001;9:4–5.
-
- Poon RT, Fan ST, Ng IO, Lo CM, Liu CL, Wong J. Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma. Cancer. 2000;89:500–507. - PubMed
-
- Matsumura M, Niwa Y, Kato N, Komatsu Y, Shiina S, Kawabe T, Kawase T, Toyoshima H, Ihori M, Shiratori Y. Detection of alpha-fetoprotein mRNA, an indicator of hematogenous spreading hepatocellular carcinoma, in the circulation: a possible predictor of metastatic hepatocellular carcinoma. Hepatology. 1994;20:1418–1425. - PubMed
-
- Komeda T, Fukuda Y, Sando T, Kita R, Furukawa M, Nishida N, Amenomori M, Nakao K. Sensitive detection of circulating hepatocellular carcinoma cells in peripheral venous blood. Cancer. 1995;75:2214–2219. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical